Rare diseases
Investigational molecules
Locations
Back to Poland827 clinical trials in Poniatowa, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy
PolandStudy on Naproxen Sodium and Paracetamol for Patients with Knee Osteoarthritis
PolandStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis
PolandStudy on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus
PolandStudy on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
PolandStudy on Acute Lymphoblastic Leukemia Treatment in Children and Adolescents Using Bortezomib, Blinatumomab, and Methotrexate Combination
PolandStudy on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack
PolandStudy of AZD7798 compared to placebo in patients with moderate to severe Crohn's disease
PolandStudy of Pacritinib for Patients with Severe Thrombocytopenia in Myelofibrosis Conditions
PolandStudy on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma
PolandStudy of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hyperlipidemia management, specifically targeting patients at high and very high cardiovascular risk. The research evaluates the effectiveness of rosuvastatin treatments and combination therapies in achieving optimal LDL-C reduction.
These studies aim to establish more effective treatment protocols for patients requiring intensive lipid-lowering therapy.
Comprehensive research evaluating biosimilar treatments for rheumatoid arthritis. The trials compare the efficacy of new biosimilar options with established treatments, focusing on patients with moderate to severe disease conditions.
This research aims to expand treatment options while maintaining high efficacy standards in rheumatoid arthritis management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
